Variant report
Variant | esv33037 |
---|---|
Chromosome Location | chr4:124560634-124563928 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SPRY1-4 | chr4:124561437-124561699 | NONHSAT098193 |
2 | lnc-SPRY1-2 | chr4:124560706-124560877 | NONHSAT098194 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147816654 | chr4:124560636-124560637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575088752 | chr4:124560642-124560643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537215338 | chr4:124560654-124560655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557554243 | chr4:124560663-124560664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs577245499 | chr4:124560678-124560679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs193106973 | chr4:124560685-124560686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553399761 | chr4:124560690-124560691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553638000 | chr4:124560694-124560695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs75392641 | chr4:124560715-124560716 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs78379215 | chr4:124560716-124560717 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs2911938 | chr4:124560835-124560836 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs370472309 | chr4:124560836-124560837 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs2911939 | chr4:124560841-124560842 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs376330962 | chr4:124560877-124560878 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs561799325 | chr4:124560880-124560881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141267827 | chr4:124560951-124560952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185838347 | chr4:124560974-124560975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188203706 | chr4:124560977-124560978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181072710 | chr4:124560999-124561000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374700359 | chr4:124561056-124561057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs141336116 | chr4:124561101-124561102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs566235085 | chr4:124561106-124561107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs368298987 | chr4:124561128-124561129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544245703 | chr4:124561138-124561139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs548586103 | chr4:124561145-124561146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563217114 | chr4:124561161-124561162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187157670 | chr4:124561183-124561184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537778327 | chr4:124561192-124561193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201483949 | chr4:124561200-124561201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370884686 | chr4:124561221-124561222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192131593 | chr4:124561298-124561299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183908517 | chr4:124561307-124561308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540040819 | chr4:124561319-124561320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553462994 | chr4:124561360-124561361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573389130 | chr4:124561387-124561388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs4833934 | chr4:124561418-124561419 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs186865741 | chr4:124561430-124561431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs367860033 | chr4:124561438-124561439 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs575431835 | chr4:124561446-124561447 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs190622092 | chr4:124561451-124561452 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs564120434 | chr4:124561472-124561473 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs532919097 | chr4:124561524-124561525 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs79747824 | chr4:124561525-124561526 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs540049494 | chr4:124561582-124561583 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs528294264 | chr4:124561611-124561612 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs147598884 | chr4:124561614-124561615 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs12647685 | chr4:124561620-124561621 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs7672183 | chr4:124561630-124561631 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs182444135 | chr4:124561707-124561708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568869416 | chr4:124561732-124561733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Developmental delay | 21147756 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:124553800-124564400 | Weak transcription | Colon Smooth Muscle | Colon |
2 | chr4:124558400-124569800 | Weak transcription | Psoas Muscle | Psoas |
3 | chr4:124560000-124562400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr4:124560400-124569000 | Weak transcription | Fetal Muscle Leg | muscle |
5 | chr4:124560600-124568600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr4:124561600-124561800 | Enhancers | NHDF-Ad | bronchial |
7 | chr4:124561600-124562000 | Weak transcription | Fetal Kidney | kidney |
8 | chr4:124561600-124562000 | Enhancers | HMEC | breast |
9 | chr4:124562000-124562200 | ZNF genes & repeats | Fetal Kidney | kidney |
10 | chr4:124562200-124564200 | Weak transcription | Fetal Kidney | kidney |
11 | chr4:124562400-124562600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr4:124562400-124562800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr4:124562600-124562800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
14 | chr4:124562600-124562800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr4:124562600-124562800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
16 | chr4:124562600-124564000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr4:124563000-124564200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
18 | chr4:124563000-124564200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
19 | chr4:124563000-124564600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
20 | chr4:124563600-124565400 | Enhancers | HUES64 Cell Line | embryonic stem cell |